Study Overview The research centered on pseudohypacusis—commonly known as non-organic hearing loss—an intriguing condition where individuals present with hearing deficiencies […]
Ocrelizumab and Colitis Risk Ocrelizumab is a monoclonal antibody primarily utilized in the treatment of multiple sclerosis (MS) and certain
Ocrelizumab-induced colitis acutely managed with ciclosporin Read Post »
Study Overview This cohort study aims to investigate the phenomenon of pseudohypacusis, commonly referred to as false hearing loss, in
Patient Characteristics This cohort study involved a diverse group of participants diagnosed with pseudohypacusis, a condition where individuals exhibit hearing
Understanding Pseudohypacusis Pseudohypacusis refers to a condition where a person demonstrates apparent hearing loss that cannot be attributed to any
Pseudohypacusis Characteristics Pseudohypacusis, often referred to as factitious hearing loss, is characterized by an apparent discrepancy between a patient’s reported
Study Overview This research focuses on pseudohypacusis, a condition characterized by a discrepancy between a patient’s reported hearing difficulties and
Overview of Pseudohypacusis Pseudohypacusis, often referred to as non-organic hearing loss, encompasses a range of conditions where an individual presents
Pseudohypacusis Overview Pseudohypacusis, often referred to as malingered hearing loss, is a condition where an individual presents with hearing impairment
Clinical Presentation Pseudohypacusis, commonly referred to as non-organic hearing loss, presents a unique challenge in clinical settings. Individuals may exhibit
